2020 is coming to an end. For the coming year 2021, I believe that many pharmaceutical machinery people are full of expectations and are fully prepared. Looking back on the development trend of pharmaceutical equipment industry in 2020, the author thinks that four key words can be used to define the concept, which are internationalization, high-end, customized and intelligent.
The data shows that the average growth rate of the annual export value of China's pharmaceutical equipment industry has reached 23.075%. With the continuous development of domestic pharmaceutical equipment industry, as well as the continuous technological breakthrough of some powerful enterprises, more and more pharmaceutical machinery enterprises are on the road of international development while meeting the domestic market demand.
For example, pharmaceutical machinery enterprises have been gaining new markets overseas. At present, they have successfully entered western Europe, North America and other high-level markets, and some high-level production lines such as anti-tumor have also entered the European and American markets. Especially in the European market, compared with the previous five years, there has been a significant increase.
From the perspective of low-cost pharmaceutical equipment, we need to speed up the pace of internationalization of pharmaceutical equipment, but we need to improve the overall competitiveness of pharmaceutical equipment from low-cost to high-level.
With the advantages of low price and convenient maintenance, the domestic medicine machine has basically realized the import substitution in the low-end field, but it still needs to continue to make efforts in the middle and high-end market. In recent years, the industry has also generally recognized that China's pharmaceutical equipment industry is lack of high-end equipment, lack of high-tech high-end pharmaceutical equipment manufacturers and other issues.
Since the beginning of this year, some innovative enterprises have begun to make efforts in the high-end field, and have made some progress. For example, the high-end pharmaceutical equipment industrialization project of Xinma pharmaceutical is expected to be officially put into operation by the end of this year. The start of the project marks the further upgrading of technological innovation of Xinma pharmaceutical. At the same time, the company will form a whole industry chain of solid preparation laboratory, customized, production-oriented and closed production lines, and become a complete solution provider providing stable and reliable solid preparation equipment for domestic and foreign customers.
With the promotion of consistency evaluation, normalization of procurement with volume, and continuous upgrading of domestic pharmaceutical industry, upstream pharmaceutical equipment has also begun to pursue high-end technology and equipment. In addition, a series of policies support the development of high-end pharmaceutical equipment. The industry expects that the market demand of medium and high-end pharmaceutical machinery in China will break out in the future.